High expression of KCa3.1 in patients with clear cell renal carcinoma predicts high metastatic risk and poor survival

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Rabjerg, Maj ^a   Oliván Viguera, Aida ^b   Hansen, Lars Koch ^c   Jensen, Line ^a   Sevelsted Møller, Linda ^c   Walter, Steen ^a   Jensen, Boye L ^c   Marcussen, Niels ^a   Köhler, Ralf ^b,d  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d FUNDACIÓN ARAID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

1 [(2 CHLOROPHENYL)DIPHENYLMETHYL] 1H PYRAZOLE; COMPLEMENTARY DNA; CYTOKERATIN 7; DEOXYRIBONUCLEASE; INTERMEDIATE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; INTERMEDIATE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL KCA1.1; INTERMEDIATE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL KCA3.1; MESSENGER RNA; RIBONUCLEASE; TRANSCRIPTION FACTOR PAX8; UNCLASSIFIED DRUG; VIMENTIN; KCNN4 PROTEIN, HUMAN; TUMOR PROTEIN;

ADULT; ARTICLE; CALCIUM HOMEOSTASIS; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; CAPILLARY DENSITY; CD8+ T LYMPHOCYTE; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE SPECIFIC SURVIVAL; DNA SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; METASTASIS POTENTIAL; MIDDLE AGED; NATURAL KILLER CELL; ONCOCYTOMA; OVERALL SURVIVAL; PATCH CLAMP TECHNIQUE; PREDICTION; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; TUMOR VOLUME; AGED; BIOSYNTHESIS; GENE EXPRESSION REGULATION; KIDNEY TUMOR; METABOLISM; MORTALITY; PATHOLOGY; SURVIVAL RATE; TUMOR CELL LINE;

ADULT; AGED; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERMEDIATE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM PROTEINS; SURVIVAL RATE;

EID: 84927534756     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0122992     Document Type: Article

References (75)

1. Ljungberg B, Campbell SC, Choi HY, Jacqmin D, Lee JE, Weikert S et al. (2011) The epidemiology of renal cell carcinoma. Eur Urol 60: 615-621. doi: 10.1016/j.eururo.2011.06.049 PMID: 21741761
2. Ishii TM, Silvia C, Hirschberg B, Bond CT, Adelman JP, Maylie J et al. (1997) A human intermediate conductance calcium-activated potassium channel. Proc Natl Acad Sci U S A 94: 11651-11656. PMID: 9326665
3. Wei AD, Gutman GA, Aldrich R, Chandy KG, Grissmer S, Wulff H et al. (2005) International Union of Pharmacology. LII. Nomenclature and molecular relationships of calcium-activated potassium channels. Pharmacol Rev 57: 463-472. PMID: 16382103
4. Wulff H, Kolski-Andreaco A, Sankaranarayanan A, Sabatier JM, Shakkottai V (2007) Modulators of small- and intermediate-conductance calcium-activated potassium channels and their therapeutic indications. Curr Med Chem 14: 1437-1457. PMID: 17584055
5. Thompson-Vest N, Shimizu Y, Hunne B, Furness JB (2006) The distribution of intermediate-conductance, calcium-activated, potassium (IK) channels in epithelial cells. J Anat 208: 219-229. PMID: 16441566
6. Kohler R, Wulff H, Eichler I, Kneifel M, Neumann D, Knorr A et al. (2003) Blockade of the intermediate-conductance calcium-activated potassium channel as a new therapeutic strategy for restenosis. Circulation 108: 1119-1125. PMID: 12939222
7. Tharp DL, Wamhoff BR, Wulff H, Raman G, Cheong A, Bowles DK et al. (2008) Local delivery of the KCa3.1 blocker, TRAM-34, prevents acute angioplasty-induced coronary smooth muscle phenotypic modulation and limits stenosis. Arterioscler Thromb Vasc Biol 28: 1084-1089. doi: 10.1161/ATVBAHA.107.155796 PMID: 18309114
8. Grgic I, Kiss E, Kaistha BP, Busch C, Kloss M, Sautter J et al. (2009) Renal fibrosis is attenuated by targeted disruption of KCa3.1 potassium channels. Proc Natl Acad Sci U S A 106: 14518-14523. doi: 10.1073/pnas.0903458106 PMID: 19706538
9. Wang ZH, Shen B, Yao HL, Jia YC, Ren J, Feng YJ et al. (2007) Blockage of intermediate-conductance-Ca(2+)-activated K(+) channels inhibits progression of human endometrial cancer. Oncogene 26: 5107-5114. PMID: 17310992
10. Ruggieri P, Mangino G, Fioretti B, Catacuzzeno L, Puca R, Ponti D et al. (2012) The inhibition of KCa3.1 channels activity reduces cell motility in glioblastoma derived cancer stem cells. PLoS One 7: e47825. doi: 10.1371/journal.pone.0047825 PMID: 23110108
11. Yang XW, Liu JW, Zhang RC, Yin Q, Shen WZ, Yi JL et al. (2013) Inhibitory effects of blockage of intermediate conductance Ca(2+)-activated K (+) channels on proliferation of hepatocellular carcinoma cells. J Huazhong Univ Sci Technolog Med Sci 33: 86-89. doi: 10.1007/s11596-013-1076-0 PMID: 23392713
12. Turner KL, Honasoge A, Robert SM, McFerrin MM, Sontheimer H (2014) A proinvasive role for the Ca (2+)-activated K(+) channel KCa3.1 in malignant glioma. Glia 62: 971-981. doi: 10.1002/glia.22655 PMID: 24585442
13. Haren N, Khorsi H, Faouzi M, Ahidouch A, Sevestre H, Ouadid-Ahidouch H et al. (2010) Intermediate conductance Ca2+ activated K+ channels are expressed and functional in breast adenocarcinomas: correlation with tumour grade and metastasis status. Histol Histopathol 25: 1247-1255. PMID: 20712009
14. Lallet-Daher H, Roudbaraki M, Bavencoffe A, Mariot P, Gackiere F, Bidaux G et al. (2009) Intermedi-ate- conductance Ca2+-activated K+ channels (IKCa1) regulate human prostate cancer cell proliferation through a close control of calcium entry. Oncogene 28: 1792-1806. doi: 10.1038/onc.2009.25 PMID: 19270724
15. Parihar AS, Coghlan MJ, Gopalakrishnan M, Shieh CC (2003) Effects of intermediate-conductance Ca2+-activated K+ channel modulators on human prostate cancer cell proliferation. Eur J Pharmacol 471: 157-164. PMID: 12826234
16. Ouadid-Ahidouch H, Roudbaraki M, Delcourt P, Ahidouch A, Joury N, Prevarskaya N et al. (2004) Functional and molecular identification of intermediate-conductance Ca(2+)-activated K(+) channels in breast cancer cells: association with cell cycle progression. Am J Physiol Cell Physiol 287: C125-134. PMID: 14985237
17. Jager H, Dreker T, Buck A, Giehl K, Gress T, Grissmer S et al. (2004) Blockage of intermediate-conductance Ca2+-activated K+ channels inhibit human pancreatic cancer cell growth in vitro. Mol Pharmacol 65: 630-638. PMID: 14978241
18. Nilius B, WohlrabW(1992) Potassium channels and regulation of proliferation of human melanoma cells. J Physiol 445: 537-548. PMID: 1323670
19. Skryma RN, Prevarskaya NB, Dufy-Barbe L, Odessa MF, Audin J, Dufy B et al. (1997) Potassium conductance in the androgen-sensitive prostate cancer cell line, LNCaP: involvement in cell proliferation. Prostate 33: 112-122. PMID: 9316652
20. Grgic I, Eichler I, Heinau P, Si H, Brakemeier S, Hoyer J et al. (2005) Selective blockade of the intermediate-conductance Ca2+-activated K+ channel suppresses proliferation of microvascular and macrovascular endothelial cells and angiogenesis in vivo. Arterioscler Thromb Vasc Biol 25: 704-709. PMID: 15662023
21. Kohler R, Degenhardt C, Kuhn M, Runkel N, Paul M, Hoyer J et al. (2000) Expression and function of endothelial Ca(2+)-activated K(+) channels in human mesenteric artery: A single-cell reverse transcriptase-polymerase chain reaction and electrophysiological study in situ. Circ Res 87: 496-503. PMID: 10988242
22. Fanger CM, Rauer H, Neben AL, Miller MJ, Rauer H, Wulff H et al. (2001) Calcium-activated potassium channels sustain calcium signaling in T lymphocytes. Selective blockers and manipulated channel expression levels. J Biol Chem 276: 12249-12256. PMID: 11278890
23. Ghanshani S, Wulff H, Miller MJ, Rohm H, Neben A, Gutman GA et al. (2000) Up-regulation of the IKCa1 potassium channel during T-cell activation. Molecular mechanism and functional consequences. J Biol Chem 275: 37137-37149. PMID: 10961988
24. Khanna R, Chang MC, Joiner WJ, Kaczmarek LK, Schlichter LC (1999) hSK4/hIK1, a calmodulin-binding KCa channel in human T lymphocytes. Roles in proliferation and volume regulation. J Biol Chem 274: 14838-14849. PMID: 10329683
25. Chandy KG, Wulff H, Beeton C, Pennington M, Gutman GA, Cahalan MD et al. (2004) K+ channels as targets for specific immunomodulation. Trends Pharmacol Sci 25: 280-289. PMID: 15120495
26. Si H, Grgic I, Heyken WT, Maier T, Hoyer J, Reusch HP et al. (2006) Mitogenic modulation of Ca2+-activated K+ channels in proliferating A7r5 vascular smooth muscle cells. Br J Pharmacol 148: 909-917. PMID: 16770324
27. Flores CA, Melvin JE, Figueroa CD, Sepulveda FV (2007) Abolition of Ca2+-mediated intestinal anion secretion and increased stool dehydration in mice lacking the intermediate conductance Ca2+-dependent K+ channel Kcnn4. J Physiol 583: 705-717. PMID: 17584847
28. Köhler R, Ruth P (2010) Endothelial dysfunction and blood pressure alterations in K+-channel transgenic mice. Pflugers Arch 459: 969-976. doi: 10.1007/s00424-010-0819-z PMID: 20349244
29. McFerrin MB, Turner KL, Cuddapah VA, Sontheimer H (2012) Differential role of IK and BK potassium channels as mediators of intrinsic and extrinsic apoptotic cell death. Am J Physiol Cell Physiol 303: C1070-1078. doi: 10.1152/ajpcell.00040.2012 PMID: 22992678
30. Hua X, Deuse T, Chen YJ, Wulff H, Stubbendorff M, Kohler R et al. (2013) The potassium channel KCa3.1 as new therapeutic target for the prevention of obliterative airway disease. Transplantation 95: 285-292. doi: 10.1097/TP.0b013e318275a2f4 PMID: 23325003
31. Qian X, Francis M, Kohler R, Solodushko V, Lin M, Taylor MS et al. (2014) Positive feedback regulation of agonist-stimulated endothelial Ca2+ dynamics by KCa3.1 channels in mouse mesenteric arteries. Arterioscler Thromb Vasc Biol 34: 127-135. doi: 10.1161/ATVBAHA.113.302506 PMID: 24177326
32. Kiefer H, Blume AJ, Kaback HR (1980) Membrane potential changes during mitogenic stimulation of mouse spleen lymphocytes. Proc Natl Acad Sci U S A 77: 2200-2204. PMID: 6929546
33. Strobl JS, Wonderlin WF, Flynn DC (1995) Mitogenic signal transduction in human breast cancer cells. Gen Pharmacol 26: 1643-1649. PMID: 8745151
34. D'Alessandro G, Catalano M, Sciaccaluga M, Chece G, Cipriani R, Rosito M et al. (2013) KCa3.1 channels are involved in the infiltrative behavior of glioblastoma in vivo. Cell Death Dis 4: e773. doi: 10.1038/cddis.2013.279 PMID: 23949222
35. Koshy S, Wu D, Hu X, Tajhya RB, Huq R, Khan FS et al. (2013) Blocking KCa3.1 channels increases tumor cell killing by a subpopulation of human natural killer lymphocytes. PLoS One 8: e76740. doi: 10.1371/journal.pone.0076740 PMID: 24146918
36. Quirk JC, Reinhart PH (2001) Identification of a novel tetramerization domain in large conductance K (ca) channels. Neuron 32: 13-23. PMID: 11604135
37. Tseng-Crank J, Foster CD, Krause JD, Mertz R, Godinot N, DiChiara TJ et al. (1994) Cloning, expression, and distribution of functionally distinct Ca(2+)-activated K+ channel isoforms from human brain. Neuron 13: 1315-1330. PMID: 7993625
38. Zhou XB, Wang GX, Ruth P, Huneke B, Korth M (2000) BK(Ca) channel activation by membrane-associated cGMP kinase may contribute to uterine quiescence in pregnancy. Am J Physiol Cell Physiol 279: C1751-1759. PMID: 11078689
39. Robitaille R, Charlton MP (1992) Presynaptic calcium signals and transmitter release are modulated by calcium-activated potassium channels. J Neurosci 12: 297-305. PMID: 1370323
40. Amberg GC, Bonev AD, Rossow CF, Nelson MT, Santana LF (2003) Modulation of the molecular composition of large conductance, Ca(2+) activated K(+) channels in vascular smooth muscle during hypertension. J Clin Invest 112: 717-724. PMID: 12952920
41. Amberg GC, Santana LF (2003) Downregulation of the BK channel beta1 subunit in genetic hypertension. Circ Res 93: 965-971. PMID: 14551242
42. Welling PA (2013) Regulation of renal potassium secretion: molecular mechanisms. Semin Nephrol 33: 215-228. doi: 10.1016/j.semnephrol.2013.04.002 PMID: 23953799
43. Grimm PR, Sansom SC (2007) BK channels in the kidney. Curr Opin Nephrol Hypertens 16: 430-436. PMID: 17693758
44. Ouadid-Ahidouch H, Roudbaraki M, Ahidouch A, Delcourt P, Prevarskaya N (2004) Cell-cycle-dependent expression of the large Ca2+-activated K+ channels in breast cancer cells. Biochem Biophys Res Commun 316: 244-251. PMID: 15003537
45. Wonderlin WF, Strobl JS (1996) Potassium channels, proliferation and G1 progression. J Membr Biol 154: 91-107. PMID: 8929284
46. Basrai D, Kraft R, Bollensdorff C, Liebmann L, Benndorf K, Patt S et al. (2002) BK channel blockers inhibit potassium-induced proliferation of human astrocytoma cells. Neuroreport 13: 403-407. PMID: 11930149
47. Bloch M, Ousingsawat J, Simon R, Schraml P, Gasser TC, Mihatsch MJ et al. (2007) KCNMA1 gene amplification promotes tumor cell proliferation in human prostate cancer. Oncogene 26: 2525-2534. PMID: 17146446
48. Van Coppenolle F, Skryma R, Ouadid-Ahidouch H, Slomianny C, Roudbaraki M, Delcourt P et al. (2004) Prolactin stimulates cell proliferation through a long form of prolactin receptor and K+ channel activation. Biochem J 377: 569-578. PMID: 14565846
49. Oeggerli M, Tian Y, Ruiz C, Wijker B, Sauter G, Obermann E et al. (2012) Role of KCNMA1 in breast cancer. PLoS One 7: e41664. doi: 10.1371/journal.pone.0041664 PMID: 22899999
50. Hes O, Michal M, Kuroda N, Martignoni G, Brunelli M, Lu Y et al. (2007) Vimentin reactivity in renal oncocytoma: immunohistochemical study of 234 cases. Arch Pathol Lab Med 131: 1782-1788. PMID: 18081436
51. http://www.biogazelle.com/qbaseplus.
52. GeNorm (2013) http://medgen.ugent.be/~jvdesomp/genorm/ Ref type: Data File.
53. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A et al. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: RESEARCH0034. PMID: 12184808
54. Bjerregaard H, Pedersen S, Kristensen SR, Marcussen N (2011) Reference genes for gene expression analysis by real-time reverse transcription polymerase chain reaction of renal cell carcinoma. Diagn Mol Pathol 20: 212-217. doi: 10.1097/PDM.0b013e318212e0a9 PMID: 22089348
55. Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J (2007) qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 8: R19. PMID: 17291332
56. Pfaffl MW(2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45. PMID: 11328886
57. Lambertsen KL, Gramsbergen JB, Sivasaravanaparan M, Ditzel N, Sevelsted-Moller LM, Olivan-Viguera A et al. (2012) Genetic KCa3.1-deficiency produces locomotor hyperactivity and alterations in cerebral monoamine levels. PLoS One 7: e47744. doi: 10.1371/journal.pone.0047744 PMID: 23077667
58. Carpenter AE, Jones TR, Lamprecht MR, Clarke C, Kang IH, Friman O et al. (2006) CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol 7: R100. PMID: 17076895
59. Olivan-Viguera A, Valero MS, Murillo MD, Wulff H, Garcia-Otin AL, Arbones-Mainar JM et al. (2013) Novel phenolic inhibitors of small/intermediate-conductance Ca(2)(+)-activated K(+) channels, KCa3.1 and KCa2.3. PLoS One 8: e58614. doi: 10.1371/journal.pone.0058614 PMID: 23516517
60. Abdullaev IF, Rudkouskaya A, Mongin AA, Kuo YH (2010) Calcium-activated potassium channels BK and IK1 are functionally expressed in human gliomas but do not regulate cell proliferation. PLoS One 5: e12304. doi: 10.1371/journal.pone.0012304 PMID: 20808839
61. Olivan-Viguera A, Valero MS, Badorrey R, Köhler R. (2014) Innovative negative-gating modulators of KCa2/3 potassium channels as new pharmacological tools. Acta Physiol (Oxf) 2014 Sept; 212(Suppl S698):32).
62. Altman DG, Lausen B, Sauerbrei W, Schumacher M (1994) Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst 86: 829-835. PMID: 8182763
63. Lewis RS (2001) Calcium signaling mechanisms in T lymphocytes. Annu Rev Immunol 19: 497-521. PMID: 11244045
64. Wulff H, Miller MJ, Hansel W, Grissmer S, Cahalan MD, Chandy KG et al. (2000) Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1: a potential immunosuppressant. Proc Natl Acad Sci U S A 97: 8151-8156. PMID: 10884437
65. Strobaek D, Christophersen P, Holm NR, Moldt P, Ahring PK, Johansen TE et al. (1996) Modulation of the Ca(2+)-dependent K+ channel, hslo, by the substituted diphenylurea NS 1608, paxilline and internal Ca2+. Neuropharmacology 35: 903-914. PMID: 8938721
66. Romine JL, Martin SW, Meanwell NA, Gribkoff VK, Boissard CG, Dworetzky SI et al. (2007) 3-[(5-Chloro-2-hydroxyphenyl)methyl]-5-[4-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2(3H)-one, BMS-191011: opener of large-conductance Ca(2+)-activated potassium (maxi-K) channels, identification, solubility, and SAR. J Med Chem 50: 528-542. PMID: 17266205
67. Mijatovic T, Dufrasne F, Kiss R (2012) Cardiotonic steroids-mediated targeting of the Na(+)/K (+)-ATPase to combat chemoresistant cancers. Curr Med Chem 19: 627-646. PMID: 22204337
68. Cuddapah VA, Sontheimer H (2011) Ion channels and transporters [corrected] in cancer. 2. Ion channels and the control of cancer cell migration. Am J Physiol Cell Physiol 301: C541-549. doi: 10.1152/ajpcell.00102.2011 PMID: 21543740
69. Pardo LA, StuhmerW(2014) The roles of K(+) channels in cancer. Nat Rev Cancer 14: 39-48. doi: 10.1038/nrc3635 PMID: 24336491
70. Arcangeli A, Crociani O, Bencini L (2014) Interaction of tumour cells with their microenvironment: ion channels and cell adhesion molecules. A focus on pancreatic cancer. Philos Trans R Soc Lond B Biol Sci 369: 20130101. doi: 10.1098/rstb.2013.0101 PMID: 24493749
71. Chantome A, Potier-Cartereau M, Clarysse L, Fromont G, Marionneau-Lambot S, Gueguinou M et al. (2013) Pivotal role of the lipid Raft SK3-Orai1 complex in human cancer cell migration and bone metastases. Cancer Res 73: 4852-4861. doi: 10.1158/0008-5472.CAN-12-4572 PMID: 23774210
72. Girault A, Haelters JP, Potier-Cartereau M, Chantome A, Jaffres PA, Bougnoux P et al. (2012) Targeting SKCa channels in cancer: potential new therapeutic approaches. Curr Med Chem 19: 697-713. PMID: 22204342
73. Grgic I, Wulff H, Eichler I, Flothmann C, Kohler R, Hoyer J et al. (2009) Blockade of T-lymphocyte KCa3.1 and Kv1.3 channels as novel immunosuppression strategy to prevent kidney allograft rejection. Transplant Proc 41: 2601-2606. doi: 10.1016/j.transproceed.2009.06.025 PMID: 19715983
74. Wulff H, Castle NA (2010) Therap eutic potential of KCa3.1 blockers: recent advances and promising trends. Expert Rev Clin Pharmacol 3: 385-396. doi: 10.1586/ecp.10.11 PMID: 22111618
75. Liu H, Brannon AR, Reddy AR, Alexe G, Seiler MW, Arreola A et al. (2010) Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma. BMC Syst Biol 4: 51. doi: 10.1186/1752-0509-4-51 PMID: 20420713